Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis

BACKGROUND: Autologous haematopoietic stem cell transplantation (AHSCT) is an effective treatment for patients with multiple sclerosis (MS) who have highly active disease, despite the use of standard disease-modifying therapies (DMTs). However, the optimal time for offering AHSCT to patients with ‘a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mult Scler
Hlavní autoři: Das, J, Snowden, JA, Burman, J, Freedman, MS, Atkins, H, Bowman, M, Burt, RK, Saccardi, R, Innocenti, C, Mistry, S, Laud, PJ, Jessop, H, Sharrack, B
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2021
Témata:
Original Research Papers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8226372/
https://ncbi.nlm.nih.gov/pubmed/33565902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458520985238
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky